Annual Interest Expense
N/A
December 31, 2023
Summary
- RSLS annual interest expense is not available.
Performance
RSLS Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
N/A
September 30, 2024
Summary
- RSLS quarterly interest expense is not available.
Performance
RSLS Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
September 30, 2024
Summary
- RSLS TTM interest expense is not available.
Performance
RSLS TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
RSLS Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
RSLS Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
ReShape Lifesciences Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $832.00 K(-59.4%) | - | - |
| Jun 2021 | - | $172.00 K(-71.3%) | $1.93 M(-24.3%) |
| Mar 2021 | - | $599.00 K(+43.6%) | $2.54 M(+24.2%) |
| Dec 2020 | $2.05 M(+354.3%) | $417.00 K(-43.6%) | $2.05 M(+21.0%) |
| Sep 2020 | - | $739.00 K(-6.3%) | $1.69 M(+64.7%) |
| Jun 2020 | - | $789.00 K(+658.7%) | $1.03 M(+127.4%) |
| Mar 2020 | - | $104.00 K(+70.5%) | $452.00 K(+0.2%) |
| Dec 2019 | $451.00 K(+3658.3%) | $61.00 K(-17.6%) | $451.00 K(+12.5%) |
| Sep 2019 | - | $74.00 K(-65.3%) | $401.00 K(+23.0%) |
| Jun 2019 | - | $213.00 K(+106.8%) | $326.00 K(+186.0%) |
| Mar 2019 | - | $103.00 K(+836.4%) | $114.00 K(+936.4%) |
| Dec 2018 | $12.00 K(+328.6%) | $11.00 K(-1200.0%) | $11.00 K(+292.9%) |
| Sep 2018 | - | -$1000.00(-200.0%) | $2800.00(-26.3%) |
| Jun 2018 | - | $1000.00(-64.3%) | $3800.00(+35.7%) |
| Dec 2017 | $2800.00(-99.9%) | $2800.00(>+9900.0%) | $2800.00(-99.6%) |
| Sep 2017 | - | $0.00(0.0%) | $710.60 K(-66.2%) |
| Jun 2017 | - | $0.00(0.0%) | $2.10 M(-28.9%) |
| Mar 2017 | - | $0.00(-100.0%) | $2.95 M(-28.0%) |
| Dec 2016 | $4.10 M(+337.0%) | $710.60 K(-48.9%) | $4.10 M(+17.5%) |
| Sep 2016 | - | $1.39 M(+63.1%) | $3.49 M(+31.0%) |
| Jun 2016 | - | $852.90 K(-25.8%) | $2.67 M(+42.3%) |
| Mar 2016 | - | $1.15 M(+1064.4%) | $1.87 M(+99.5%) |
| Dec 2015 | $939.20 K | $98.70 K(-82.5%) | $939.10 K(+0.4%) |
| Sep 2015 | - | $565.50 K(+836.3%) | $934.90 K(+90.7%) |
| Jun 2015 | - | $60.40 K(-71.8%) | $490.30 K(-14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $214.50 K(+127.0%) | $575.30 K(+8.5%) |
| Dec 2014 | $530.20 K(-43.1%) | $94.50 K(-21.8%) | $530.20 K(-16.5%) |
| Sep 2014 | - | $120.90 K(-16.9%) | $634.60 K(-14.1%) |
| Jun 2014 | - | $145.40 K(-14.2%) | $738.50 K(-12.2%) |
| Mar 2014 | - | $169.40 K(-14.8%) | $840.70 K(-9.8%) |
| Dec 2013 | $932.40 K(+3.4%) | $198.90 K(-11.5%) | $932.40 K(-6.6%) |
| Sep 2013 | - | $224.80 K(-9.2%) | $998.70 K(-3.7%) |
| Jun 2013 | - | $247.60 K(-5.2%) | $1.04 M(+1.8%) |
| Mar 2013 | - | $261.10 K(-1.5%) | $1.02 M(+13.0%) |
| Dec 2012 | $901.80 K(+24.7%) | $265.20 K(+0.6%) | $901.80 K(+13.3%) |
| Sep 2012 | - | $263.70 K(+15.0%) | $795.80 K(+13.7%) |
| Jun 2012 | - | $229.30 K(+59.7%) | $699.90 K(+10.2%) |
| Mar 2012 | - | $143.60 K(-9.8%) | $634.90 K(-12.2%) |
| Dec 2011 | $722.90 K(-42.6%) | $159.20 K(-5.1%) | $722.90 K(-14.6%) |
| Sep 2011 | - | $167.80 K(+2.1%) | $846.70 K(-12.3%) |
| Jun 2011 | - | $164.30 K(-29.1%) | $965.40 K(-14.3%) |
| Mar 2011 | - | $231.60 K(-18.2%) | $1.13 M(-10.5%) |
| Dec 2010 | $1.26 M(-69.3%) | $283.00 K(-1.2%) | $1.26 M(-51.8%) |
| Sep 2010 | - | $286.50 K(-11.9%) | $2.61 M(-19.5%) |
| Jun 2010 | - | $325.30 K(-10.5%) | $3.24 M(-14.5%) |
| Mar 2010 | - | $363.60 K(-77.8%) | $3.79 M(-7.6%) |
| Dec 2009 | $4.10 M(+52.9%) | $1.63 M(+78.1%) | $4.10 M(+66.2%) |
| Sep 2009 | - | $918.00 K(+5.0%) | $2.47 M(+59.2%) |
| Jun 2009 | - | $874.10 K(+29.0%) | $1.55 M(+129.0%) |
| Mar 2009 | - | $677.50 K | $677.50 K |
| Dec 2008 | $2.68 M | - | - |
FAQ
- What is the all time high annual interest expense for ReShape Lifesciences?
- What is the all time high quarterly interest expense for ReShape Lifesciences?
- What is the all time high TTM interest expense for ReShape Lifesciences?
What is the all time high annual interest expense for ReShape Lifesciences?
ReShape Lifesciences all-time high annual interest expense is $4.10 M
What is the all time high quarterly interest expense for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly interest expense is $1.63 M
What is the all time high TTM interest expense for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM interest expense is $4.10 M